Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1316studies shown
Showing 49-60 of 1,316
Drug study icon
RecruitingNCT07592689

Study of DT120 for Major Depressive Disorder (Ascend)

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Depression
Drug study icon
RecruitingNCT06775379

A Study of Azetukalner Versus Placebo in Major Depressive Disorder

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States
Sponsor
Xenon Pharmaceuticals Inc.
Condition
Depression
Drug study icon
RecruitingNCT07076407

A Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

The registry lists this study as recruiting. Study locations are listed in the United States, in Finland, in Germany, ...

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Finland, Germany, ...
Sponsor
Xenon Pharmaceuticals Inc.
Condition
Depression
Device study icon
RecruitingNCT05913960

Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway

This summary needs review. Please check the official study record and contact the research team for details.

In Hangzhou
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 12 Years to 45 Years
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Condition
Depression
Drug study icon
RecruitingNCT07553637

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom
Sponsor
Alto Neuroscience
Condition
Depression
Device study icon
RecruitingNCT04004169

Closed-Loop Deep Brain Stimulation for Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Andrew Krystal
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.